QQQ   283.80 (-1.63%)
AAPL   115.98 (-2.55%)
MSFT   214.22 (-2.48%)
FB   261.40 (-1.70%)
GOOGL   1,529.95 (-2.41%)
AMZN   3,207.21 (-2.00%)
TSLA   430.83 (-2.01%)
NVDA   539.91 (-2.27%)
BABA   305.29 (-0.66%)
CGC   19.81 (+11.54%)
GE   7.29 (+0.00%)
MU   52.63 (+1.98%)
AMD   82.00 (-1.41%)
T   26.88 (-1.65%)
F   7.59 (-1.04%)
ACB   4.71 (+17.16%)
GILD   60.57 (-2.31%)
NFLX   530.72 (-0.01%)
BA   167.11 (-0.14%)
BAC   23.72 (-2.15%)
DIS   124.23 (-2.03%)
QQQ   283.80 (-1.63%)
AAPL   115.98 (-2.55%)
MSFT   214.22 (-2.48%)
FB   261.40 (-1.70%)
GOOGL   1,529.95 (-2.41%)
AMZN   3,207.21 (-2.00%)
TSLA   430.83 (-2.01%)
NVDA   539.91 (-2.27%)
BABA   305.29 (-0.66%)
CGC   19.81 (+11.54%)
GE   7.29 (+0.00%)
MU   52.63 (+1.98%)
AMD   82.00 (-1.41%)
T   26.88 (-1.65%)
F   7.59 (-1.04%)
ACB   4.71 (+17.16%)
GILD   60.57 (-2.31%)
NFLX   530.72 (-0.01%)
BA   167.11 (-0.14%)
BAC   23.72 (-2.15%)
DIS   124.23 (-2.03%)
QQQ   283.80 (-1.63%)
AAPL   115.98 (-2.55%)
MSFT   214.22 (-2.48%)
FB   261.40 (-1.70%)
GOOGL   1,529.95 (-2.41%)
AMZN   3,207.21 (-2.00%)
TSLA   430.83 (-2.01%)
NVDA   539.91 (-2.27%)
BABA   305.29 (-0.66%)
CGC   19.81 (+11.54%)
GE   7.29 (+0.00%)
MU   52.63 (+1.98%)
AMD   82.00 (-1.41%)
T   26.88 (-1.65%)
F   7.59 (-1.04%)
ACB   4.71 (+17.16%)
GILD   60.57 (-2.31%)
NFLX   530.72 (-0.01%)
BA   167.11 (-0.14%)
BAC   23.72 (-2.15%)
DIS   124.23 (-2.03%)
QQQ   283.80 (-1.63%)
AAPL   115.98 (-2.55%)
MSFT   214.22 (-2.48%)
FB   261.40 (-1.70%)
GOOGL   1,529.95 (-2.41%)
AMZN   3,207.21 (-2.00%)
TSLA   430.83 (-2.01%)
NVDA   539.91 (-2.27%)
BABA   305.29 (-0.66%)
CGC   19.81 (+11.54%)
GE   7.29 (+0.00%)
MU   52.63 (+1.98%)
AMD   82.00 (-1.41%)
T   26.88 (-1.65%)
F   7.59 (-1.04%)
ACB   4.71 (+17.16%)
GILD   60.57 (-2.31%)
NFLX   530.72 (-0.01%)
BA   167.11 (-0.14%)
BAC   23.72 (-2.15%)
DIS   124.23 (-2.03%)
Log in
NASDAQ:IMAC

IMAC Stock Forecast, Price & News

$0.74
-0.09 (-10.84 %)
(As of 10/19/2020 12:00 AM ET)
Add
Compare
Today's Range
$0.73
Now: $0.74
$0.84
50-Day Range
$0.70
MA: $0.82
$1.02
52-Week Range
$0.42
Now: $0.74
$4.95
Volume275,688 shs
Average Volume521,115 shs
Market Capitalization$8.76 million
P/E RatioN/A
Dividend YieldN/A
Beta-3.18
IMAC Holdings, Inc. provides orthopedic therapies through a chain of innovative medical advancements and care regeneration centers in the United States. Its outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, back pain, knee pain, joint pain, ligament and tendon damage, and other related soft tissue conditions. As of March 26, 2020, the company owned or managed 14 outpatient clinics in Kentucky, Missouri, Tennessee, and Illinois. IMAC Holdings, Inc. was founded in 2000 and is based in Brentwood, Tennessee.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.82 out of 5 stars

Industry, Sector and Symbol

Industry Specialty outpatient clinics, not elsewhere classified
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:IMAC
CUSIPN/A
CIKN/A
Phone844-266-4622
Employees108

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$15.13 million
Book Value$0.93 per share

Profitability

Net Income$-6,500,000.00

Miscellaneous

Market Cap$8.76 million
Next Earnings Date11/12/2020 (Estimated)
OptionableNot Optionable
$0.74
-0.09 (-10.84 %)
(As of 10/19/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive IMAC News and Ratings via Email

Sign-up to receive the latest news and ratings for IMAC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











IMAC (NASDAQ:IMAC) Frequently Asked Questions

How has IMAC's stock been impacted by Coronavirus?

IMAC's stock was trading at $0.82 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, IMAC shares have decreased by 9.8% and is now trading at $0.74.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of IMAC?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for IMAC in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for IMAC
.

When is IMAC's next earnings date?

IMAC is scheduled to release its next quarterly earnings announcement on Thursday, November 12th 2020.
View our earnings forecast for IMAC
.

How were IMAC's earnings last quarter?

IMAC Holdings, Inc. (NASDAQ:IMAC) announced its earnings results on Friday, August, 14th. The company reported ($0.19) earnings per share for the quarter. The business had revenue of $2.57 million for the quarter. IMAC had a negative return on equity of 85.82% and a negative net margin of 46.65%.
View IMAC's earnings history
.

What price target have analysts set for IMAC?

2 brokers have issued 1 year price targets for IMAC's shares. Their forecasts range from $4.50 to $4.50. On average, they anticipate IMAC's share price to reach $4.50 in the next year. This suggests a possible upside of 508.1% from the stock's current price.
View analysts' price targets for IMAC
.

Are investors shorting IMAC?

IMAC saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 178,100 shares, an increase of 21.7% from the August 31st total of 146,400 shares. Based on an average daily volume of 262,400 shares, the days-to-cover ratio is presently 0.7 days. Approximately 2.5% of the shares of the company are short sold.
View IMAC's Short Interest
.

Who are some of IMAC's key competitors?

What other stocks do shareholders of IMAC own?

Based on aggregate information from My MarketBeat watchlists, some companies that other IMAC investors own include VBI Vaccines (VBIV), Biocept (BIOC), Energy Transfer (ET), Ibio (IBIO), McEwen Mining (MUX), Opko Health (OPK), Advanced Micro Devices (AMD), Amarin (AMRN), Aytu BioScience (AYTU) and BioNano Genomics (BNGO).

Who are IMAC's key executives?

IMAC's management team includes the following people:
  • Mr. Jeffrey S. Ervin M.B.A., Chairman & CEO (Age 43, Pay $239.88k)
  • Ms. Sheri Gardzina CPA, CPA, Interim CFO & Corp. Sec. (Age 52, Pay $162.04k)
  • Dr. Matthew C. Wallis, COO & Director (Age 46, Pay $257.27k)
  • Mr. Jeff Ervin, Chief Exec. Officer

When did IMAC IPO?

(IMAC) raised $4 million in an initial public offering on the week of February 11th 2019. The company issued 900,000 shares at a price of $5.00 per share. Dawson James Securities and Cuttone served as the underwriters for the IPO.

What is IMAC's stock symbol?

IMAC trades on the NASDAQ under the ticker symbol "IMAC."

How do I buy shares of IMAC?

Shares of IMAC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is IMAC's stock price today?

One share of IMAC stock can currently be purchased for approximately $0.74.

How big of a company is IMAC?

IMAC has a market capitalization of $8.76 million and generates $15.13 million in revenue each year. IMAC employs 108 workers across the globe.

What is IMAC's official website?

The official website for IMAC is www.imacregeneration.com.

How can I contact IMAC?

IMAC's mailing address is 1605 WESTGATE CIRCLE, BRENTWOOD TN, 37027. The company can be reached via phone at 844-266-4622 or via email at [email protected]

This page was last updated on 10/19/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.